Pfizer (NYSE: PFE) reported Q2 EPS of $0.67, $0.10 better than the analyst estimate of $0.57. Revenue for the quarter came in at $12.7 billion versus the consensus estimate of $12.08 billion.

GUIDANCE:

Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $3.01. Pfizer narrows FY2023 revenue to $67-70 billion, versus $67-$71 billion prior and the consensus of $61 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.